Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-18 · Built: 2026-10-18 · 中文

← United States · Coverage record

US · SEC FORM 4

Rezolute, Inc.

RZLT · Nasdaq · CIK 0001509261 · Healthcare · Biotechnology

INSIDER SIGNAL

No active buy signal

0 qualifying P purchase groups
in the current 180-day scoring window

4 Form 4 transaction lines observed in the same window
0 sales · 4 option, withholding, award, gift or other lines

Last qualifying purchase2026-03-30 · Evans Daron · $28.5K

WHY NO ACTIVE SIGNAL?

Purchase activityNone
Recent buyingNone
Recent salesNone
Buy signal statusInactive
Score anatomy

No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.

ClusterNot calculated
Purchase sizeNot calculated
RoleNot calculated
RecencyNot calculated
ConvictionNot calculated

Why is there no score?

  • No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
  • Sales and other Form 4 activity remain visible as context and do not create a negative score.

Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.

Insider activity timeline

Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.

AprMayJunJulAugSepOct
Karnawat Sunil RatilalChief Commercial Officer
○
ROBERTS BRIAN KENNETHChief Medical Officer
○
Elam Nevan CCEO
○
Evans DaronCFO
○
● Purchase▼ Sale○ Other

—

Purchase breadth, concentration & cluster buying

These modules activate when qualifying purchases enter the 180-day research window.

SIGNAL HISTORY

No recorded active-signal snapshot

Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2026-03-30 · Evans Daron.

Recent Form 4 activity

9Purchases
0Sales
17Other Form 4 lines
24SEC filings · 365 days
BUYING0 qualifying P line(s) · 180 days
SELLING0 sale line(s) · context only
OTHER4 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.

Short interest

Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.

Shares short
16,714,969
Previous report
16,814,402
Avg daily volume
1,872,511
Days to cover
8.9

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting ownerTypeSecuritySharesAvg. priceApprox. valueSource
2026-03-30Evans DaronPurchase (P)Common Shares10,000USD 2.85USD 28,500SEC filing ↗
2025-12-16ROBERTS BRIAN KENNETHPurchase (P)Common Shares28,000USD 1.70USD 47,600SEC filing ↗
2025-12-16Hogenhuis WladimirPurchase (P)Common Shares5,650USD 1.69USD 9,548SEC filing ↗
2025-12-15Karnawat Sunil RatilalPurchase (P)Common Shares12,100USD 1.62USD 19,600SEC filing ↗
2025-12-15Evans DaronPurchase (P)Common Shares42,500USD 1.77USD 75,275SEC filing ↗
2025-12-15Elam Nevan CPurchase (P)Common Shares32,000USD 1.59USD 50,880SEC filing ↗
2025-12-09Evans DaronPurchase (P)Common Shares10,549USD 5.04USD 53,167SEC filing ↗
2025-06-25ROBERTS BRIAN KENNETHPurchase (P)Common Shares2,500USD 4.38USD 10,950SEC filing ↗
2025-06-24Evans DaronPurchase (P)Common Shares5,000USD 4.05USD 20,250SEC filing ↗
2025-06-13Kim Young-JinPurchase (P)Common Shares1,230,769USD 3.25USD 3,999,999SEC filing ↗
2025-06-13KREHER NERISSAPurchase (P)Common Shares3,076USD 3.25USD 9,997SEC filing ↗
2025-03-31Hogenhuis WladimirPurchase (P)Common Shares6,758USD 2.92USD 19,733SEC filing ↗
2025-03-27Elam Nevan CPurchase (P)Common Shares12,302USD 2.85USD 35,061SEC filing ↗
2025-03-26Evans DaronPurchase (P)Common Shares20,000USD 2.88USD 57,700SEC filing ↗
2025-02-18Hogenhuis WladimirPurchase (P)Common Shares10,000USD 4.70USD 47,000SEC filing ↗

Form 4 evidence

26 transaction lines in the latest 365-day window; 161 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-09-02Karnawat Sunil RatilalTax withholding (F)Common Shares2,267USD 4.50USD 10,202SEC filing ↗
2026-07-02ROBERTS BRIAN KENNETHTax withholding (F)Common Shares3,062USD 4.99USD 15,279SEC filing ↗
2026-07-02Evans DaronTax withholding (F)Common Shares3,062USD 4.99USD 15,279SEC filing ↗
Show recent Form 4 evidence (24 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-09-02Karnawat Sunil RatilalTax withholding (F)Common Shares2,267USD 4.50USD 10,202SEC filing ↗
2026-07-02ROBERTS BRIAN KENNETHTax withholding (F)Common Shares3,062USD 4.99USD 15,279SEC filing ↗
2026-07-02Evans DaronTax withholding (F)Common Shares3,062USD 4.99USD 15,279SEC filing ↗
2026-07-02Elam Nevan CTax withholding (F)Common Shares8,004USD 4.99USD 39,940SEC filing ↗
2026-03-30Evans DaronPurchase (P)Common Shares10,000USD 2.85USD 28,500SEC filing ↗
2026-03-02ROBERTS BRIAN KENNETHTax withholding (F)Common Shares11,439USD 2.99USD 34,203SEC filing ↗
2026-03-02Evans DaronTax withholding (F)Common Shares11,438USD 2.99USD 34,200SEC filing ↗
2026-03-02Elam Nevan CTax withholding (F)Common Shares27,618USD 2.99USD 82,578SEC filing ↗
2025-12-16ROBERTS BRIAN KENNETHPurchase (P)Common Shares28,000USD 1.70USD 47,600SEC filing ↗
2025-12-16Hogenhuis WladimirPurchase (P)Common Shares5,650USD 1.69USD 9,548SEC filing ↗
2025-12-15Karnawat Sunil RatilalPurchase (P)Common Shares12,100USD 1.62USD 19,600SEC filing ↗
2025-12-15Evans DaronPurchase (P)Common Shares42,500USD 1.77USD 75,275SEC filing ↗
2025-12-15Elam Nevan CPurchase (P)Common Shares32,000USD 1.59USD 50,880SEC filing ↗
2025-12-09Evans DaronPurchase (P)Common Shares10,549USD 5.04USD 53,167SEC filing ↗
2025-11-19ROBERTS BRIAN KENNETHAward / grant (A)Common Shares123,000USD 0.00USD 0SEC filing ↗
2025-11-19Labrucherie Gil MAward / grant (A)Common Shares21,000USD 0.00USD 0SEC filing ↗
2025-11-19Kim Young-JinAward / grant (A)Common Shares21,000USD 0.00USD 0SEC filing ↗
2025-11-19Karnawat Sunil RatilalAward / grant (A)Common Shares32,000USD 0.00USD 0SEC filing ↗
2025-11-19KREHER NERISSAAward / grant (A)Common Shares21,000USD 0.00USD 0SEC filing ↗
2025-11-19Hogenhuis WladimirAward / grant (A)Common Shares21,000USD 0.00USD 0SEC filing ↗
2025-11-19Harris ErikAward / grant (A)Common Shares21,000USD 0.00USD 0SEC filing ↗
2025-11-19FAUCHET PHILIPPEAward / grant (A)Common Shares21,000USD 0.00USD 0SEC filing ↗
2025-11-19Evans DaronAward / grant (A)Common Shares107,000USD 0.00USD 0SEC filing ↗
2025-11-19Elam Nevan CAward / grant (A)Common Shares317,000USD 0.00USD 0SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-18
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerRZLT
CIK0001509261
SectorHealthcare
IndustryBiotechnology Yahoo Finance
SEC SIC2834 Pharmaceutical Preparations
ExchangeNasdaq

Data coverage

Local Form 4 history161 transaction lines from 2020-07-06 to 2026-09-02
127 P purchase lines · 0 S sale lines · 34 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.